Georgetown University Lombardi Cancer Center — Washington D.C., District of Columbia

Georgetown University Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Georgetown University Lombardi Cancer Center has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Prostate Cancer, Colorectal Cancer, Extensive Stage Small Cell Lung Cancer.

Sponsors: Novacea, EMD Serono, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Lombardi Cancer Center?

Georgetown University Lombardi Cancer Center has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Lombardi Cancer Center conducted?

Georgetown University Lombardi Cancer Center has 6 clinical trials on record, with 4 currently active. Their work covers Prostate Cancer, Colorectal Cancer, Extensive Stage Small Cell Lung Cancer.

Is Georgetown University Lombardi Cancer Center accredited by Crixeo Health?

Georgetown University Lombardi Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Lombardi Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.